This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • Pharmacokinetics of Caspofungin After One Dose in ...
Clinical trial

Pharmacokinetics of Caspofungin After One Dose in Patients With Liver Failure

Read time: 1 mins
Last updated:25th Sep 2013
The objective of this study is to conduct a population pharmacokinetic analysis of caspofungin in a population of patients with moderate and severe acute alcoholic hepatitis or liver disease with Child-Pugh score B and C in order to better characterize pharmacokinetic parameters in case of moderate and severe liver dysfunction.
Category Value
Study start date 2013-09-25

View full details